National asbestos law firm Shrader & Associates LLP and three health insurers have reached a deal in a suit claiming the firm failed to pay the companies money out of its clients’ asbestos settlement funds, a Texas federal judge has said.
In this week’s Taxation With Representation, Keurig Dr. Pepper Inc. snaps up Core Nutrition LLC for $435 million, Stryker inks a $220M deal for HyperBranch Medical Technology Inc., and Honeywell International Inc. snags German warehouse automation business Transnorm for €425 million ($492 million).
A Mesquite, Texas-based bariatric surgeon who was one of the founders of Forest Park Medical Center has entered a guilty plea for his role in what the government alleges is a $40 million bribery and kickback scheme.
HealthNow New York Inc. has asked a Texas federal court just to allow it to escape an Employee Retirement Income Security Act suit from seven affiliated hospitals which had claimed that dozens of Blue Cross Blue Shield entities underpaid them by tens of millions of dollars.
The New Jersey Attorney General’s Office and OxyContin producer Purdue Pharma LP on Thursday each heralded different parts of a state court decision finding the company must face a trimmed lawsuit alleging its deceptive marketing practices contributed to the opioid epidemic.
Cancer-testing startup Guardant Health raised $238 million in an initial public offering that priced well above range and saw shares surge in debut trading Thursday, while biotechnology firm Kodiak Sciences raised $90 million in an IPO that fell short of expectations.
Nonprofit hospital chain Verity Health asked a California bankruptcy court on Wednesday to be allowed to cut its ties to a sports medicine practice, saying the contracts would cost the chain $25 million over the next nine years.
A Texas federal judge on Thursday ruled that Great American Insurance Co. wrongfully refused to cover Nobilis Health Corp.’s costs to defend two shareholder class action suits accusing Nobilis of artificially inflating its stock price, finding that the suits involved allegations similar to those in an earlier action the insurer had agreed to cover.
A New Jersey federal judge has refused to dismiss pharmaceutical information technology company Veeva Systems Inc.’s monopoly claims in its countersuit against life sciences data giant IQVIA Inc., ruling Wednesday that it plausibly alleged IQVIA tried to block customer access to its product.
Winn-Dixie Stores Inc. urged the Eleventh Circuit on Thursday to reverse a June 2017 decision that found its website violated a blind customer's rights under the Americans with Disabilities Act and opened the floodgates for lawsuits against companies over website accessibility.
Towers Watson Delaware has told a Pennsylvania state court that its former firm Morgan Lewis & Bockius, which Towers Watson sued for $30 million for allegedly working against its interests, has once again attempted to subpoena privileged documents as part of the discovery process.
A Houston medical center has asked the Texas Supreme Court to toss the remaining claims in a suit brought by a former patient who was shot and arrested by hospital security, arguing prior holdings from the court mandate dismissal.
Medical marijuana firm Tilray Inc. on Wednesday said it is rolling out a $400 million private placement of convertible senior notes in an effort to pick up additional funds for acquisitions and other business purposes, with Cooley LLP steering the British Columbia–based company.
The Federal Circuit on Thursday rejected a veteran’s appeal over the effective date of his U.S. Department of Veterans Affairs disability rating, saying a veterans court had correctly tied benefits to the date of a diagnostic test and not a doctor's recommendation for tests 14 months earlier.
Athena Diagnostics and Oxford University Innovation Ltd. on Thursday asked a Federal Circuit panel to revive their patent for a test that diagnoses an autoimmune disease based on the presence of certain antibodies, saying a lower court erred in finding the patent covered an ineligible law of nature.
A Native American tribe has asked the Ninth Circuit to rehear a dispute over government health care cost reimbursements for the tribe’s veterans, claiming the court wrongly decided it has no jurisdiction in the matter.
A group of parents have asked the Sixth Circuit to revive a suit accusing Michigan of collecting, testing, storing and selling newborns’ blood without first getting parental consent, arguing it violates a child’s Fourth and 14th Amendment rights.
Priderock Capital Partners has reportedly dropped $98 million on two Florida apartment complexes, Invesco is said to have paid $760 million for an 80 percent stake in five New York residential and retail buildings and real estate investment trust Welltower has reportedly sold a Florida health care center for $12.6 million.
The U.S. Senate on Wednesday sent a massive bipartisan bill tackling the opioid crisis to President Donald Trump after passing the wide-ranging legislation 98-1.
An anti-abortion activist can’t defeat the National Abortion Federation’s suit over surreptitiously recorded videos of its providers, a California federal judge said Wednesday, adding he had "deja vu all over again," because the arguments for dismissal were so similar to those that failed to end similar claims brought by Planned Parenthood.
A U.S. Department of Health and Human Services administrative law judge recently upheld a ruling from the Office of Inspector General against BestCare and its CEO based on submissions of false claims to Medicare for mileage reimbursement. The decision is notable as it’s the first of its kind since 2011, says David Blank of Quarles & Brady LLP.
The New York high court recently issued a decision in Anonymous v. Molik, answering several questions concerning the scope of charges that could be brought by the Justice Center for the Protection of People with Special Needs. As a result, the Justice Center can now target contractors, regulated providers and facility managers directly, says John Dow, assistant general counsel for The Arc New York.
Recent updates to the U.S. Council of Catholic Bishops' health care directives bring potential additional complexities to affiliations between Catholic and non-Catholic organizations, say Sandra DiVarco and Kerrin Slattery of McDermott Will & Emery LLP and the Rev. William Grogan of the Archdiocese of Chicago.
In this new series featuring law school luminaries, Widener University Delaware Law School dean Rodney Smolla discusses teaching philosophies, his interest in First Amendment law, and arguing before the U.S. Supreme Court in Virginia v. Black.
As lower courts decide whether to apply the U.S. Supreme Court's AmEx decision to other types of two-sided markets, the key question will be whether allegedly anti-competitive conduct on one side of a platform may be credibly constrained by indirect network effects on the other, say Barry Reingold and David Chiappetta of Perkins Coie LLP.
A few weeks ago, the IRS proposed regulations related to the Tax Cuts and Jobs Act's 20 percent deduction on qualified business income for pass-through entities. The guidance offers long-awaited clarity, but is mostly bad news for many law firms, says Evan Morgan of Kaufman Rossin PA.
Judicial impeachment fever seems to be spreading through the states, with West Virginia legislators recently voting to remove their state's entire Supreme Court, and lawmakers in Pennsylvania and North Carolina threatening the same. These actions are a serious threat to judicial independence, says Jan van Zyl Smit of the Bingham Centre for the Rule of Law.
In this time of partisan conflict over judicial selection, a new book by Canadian jurist Robert J. Sharpe — "Good Judgment" — represents a refreshing, deeply thoughtful departure from binary arguments about how and why judges make decisions, says U.S. District Judge Jeremy Fogel, director of the Federal Judicial Center.
E-discovery is not easy, but employing these 10 strategies may help minimize future headaches, say Debbie Reynolds and Daryl Gardner of EimerStahl Discovery Solutions LLC.
In Sali v. Corona Regional Medical Center the Ninth Circuit recently ruled that evidence offered in support of class certification need not be admissible at trial. Attorneys with Foley & Lardner LLP discuss the Sali court’s analysis and holding, how the decision directly conflicts with most other circuits, and its likely impact on class action defendants.